Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study
- PMID: 18539224
- DOI: 10.1016/S0140-6736(08)60834-X
Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study
Erratum in
- Lancet. 2008 Dec 13;372(9655):2022
Abstract
Background: Results of several studies published since 1999 suggest that primary hyperaldosteronism (also known as Conn's syndrome) affects more than 10% of people with hypertension; however, such a high prevalence has also been disputed. Experts generally agree that resistant hypertension has the highest prevalence of primary hyperaldosteronism, on the basis of small studies. We aimed to assess the prevalence of primary hyperaldosteronism in a large group of patients with resistant hypertension.
Methods: Patients with resistant hypertension (blood pressure >140/90 mm Hg despite a three drug regimen, including a diuretic) who attended our outpatient clinic were assessed for primary hyperaldosteronism. Serum aldosterone and plasma renin activity were determined and their ratio was calculated. Patients with a positive test (ratio >65.16 and aldosterone concentrations >416 pmol/L) underwent salt suppression tests with intravenous saline and fludrocortisone. Diagnosis of primary hyperaldosteronism was further confirmed by the response to treatment with spironolactone.
Findings: Over 20 years, we studied 1616 patients with resistant hypertension. 338 patients (20.9%) had a ratio of more than 65.16 and aldosterone concentrations of more than 416 pmol/L. On the basis of salt suppression tests, 182 (11.3%) patients had primary hyperaldosteronism, and response to spironolactone treatment further confirmed this diagnosis. Hypokalaemia was seen only in 83 patients with primary hyperaldosteronism (45.6%).
Interpretation: Although the prevalence of primary hyperaldosteronism in patients with resistant hypertension was high, it was substantially lower than previously reported. On the basis of this finding, we could assume that the prevalence of primary hyperaldosteronism in the general unselected hypertensive population is much lower than currently reported. Thus, the notion of an epidemic of primary hyperaldosteronism is not supported.
Comment in
-
Primary hyperaldosteronism in patients with resistant hypertension may be less prevalent than previously reported: evidence against an epidemic.J Clin Hypertens (Greenwich). 2008 Aug;10(8):655-7. doi: 10.1111/j.1751-7176.2008.08058.x. J Clin Hypertens (Greenwich). 2008. PMID: 18780479 Free PMC article. No abstract available.
Similar articles
-
Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing.Clin Med (Lond). 2005 Jan-Feb;5(1):55-60. doi: 10.7861/clinmedicine.5-1-55. Clin Med (Lond). 2005. PMID: 15745200 Free PMC article.
-
Normokalemic hyperaldosteronism in patients with resistant hypertension.Isr Med Assoc J. 2002 Jan;4(1):17-20. Isr Med Assoc J. 2002. PMID: 11802302
-
The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.Circulation. 2007 Jul 17;116(3):268-75. doi: 10.1161/CIRCULATIONAHA.107.690396. Epub 2007 Jul 2. Circulation. 2007. PMID: 17606839 Clinical Trial.
-
Primary aldosteronism: renaissance of a syndrome.Clin Endocrinol (Oxf). 2007 May;66(5):607-18. doi: 10.1111/j.1365-2265.2007.02775.x. Clin Endocrinol (Oxf). 2007. PMID: 17492946 Review.
-
Hyperaldosteronism as a common cause of resistant hypertension.Annu Rev Med. 2013;64:233-47. doi: 10.1146/annurev-med-042711-135929. Epub 2012 Oct 22. Annu Rev Med. 2013. PMID: 23092384 Review.
Cited by
-
Anatomy and anatomical variations of adrenal veins and its application to adrenal venous sampling.Surg Radiol Anat. 2024 Mar 1. doi: 10.1007/s00276-024-03331-y. Online ahead of print. Surg Radiol Anat. 2024. PMID: 38429406
-
What We Know about and What Is New in Primary Aldosteronism.Int J Mol Sci. 2024 Jan 11;25(2):900. doi: 10.3390/ijms25020900. Int J Mol Sci. 2024. PMID: 38255973 Free PMC article. Review.
-
Evaluation of a Best-Practice Advisory for Primary Aldosteronism Screening.JAMA Intern Med. 2024 Feb 1;184(2):174-182. doi: 10.1001/jamainternmed.2023.7389. JAMA Intern Med. 2024. PMID: 38190155
-
Clinical and biochemical outcomes after adrenalectomy for primary aldosteronism in tertiary and quaternary referral centers: data from SOPRANO study.Hypertens Res. 2024 Mar;47(3):721-734. doi: 10.1038/s41440-023-01554-x. Epub 2024 Jan 5. Hypertens Res. 2024. PMID: 38182902 Review.
-
Captopril challenge test: an underutilized test in the diagnosis of primary aldosteronism.Endocr Connect. 2024 Jan 24;13(3):e230445. doi: 10.1530/EC-23-0445. Print 2024 Mar 1. Endocr Connect. 2024. PMID: 38180077 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
